HLA-C Antikörper
Kurzübersicht für HLA-C Antikörper (ABIN7505980)
Target
Alle HLA-C Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Anti-HLA-C Purified
-
Produktmerkmale
- The mouse monoclonal antibody DT-9 recognizes an extracellular epitope on HLA-C member of MHC class I molecules. It does not crossreact with HLA-A or HLA-B allotypes.
-
Aufreinigung
- Purified by protein-A affinity chromatography.
-
Immunogen
- Purified MHC class I molecules of tamarin origin
-
Isotyp
- IgG2b
-
-
-
-
Applikationshinweise
- Flow cytometry: Recommended dilution: 1-4 μg/mL.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Do not freeze
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8°C. Do not freeze.
-
-
- HLA-C (Major Histocompatibility Complex Class I C (HLA-C))
-
Andere Bezeichnung
- HLA-C
-
Hintergrund
- Major histocompatibility complex, class I, C,HLA-C, a member of MHC class I glycoproteins, is one of polymorphysm typing targets, which are important for transplantation. The HLA system plays an important role in the occurrence and outcome of infectious diseases. The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population. It has been described that HLA-C interacts with human herpesvirus 8 MIR1 protein.,HLC-C, D6S204, PSORS1, HLA-JY3
-
Gen-ID
- 3107
-
UniProt
- P10321
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-